Cold- and menthol-sensitive receptor (CMR1)

US9932383B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9932383-B2
Application numberUS-201615266016-A
CountryUS
Kind codeB2
Filing dateSep 15, 2016
Priority dateJan 25, 2002
Publication dateApr 3, 2018
Grant dateApr 3, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to regulation of cold sensation and pain. More particularly, the present invention is directed to nucleic acids encoding a member of the transient regulatory protein family, CMR1, which is involved in modulation of the perception of cold sensations and pain. In some embodiments, an isolated or recombinant CMR1 polypeptide is directly or indirectly attached to a detectable label or fused to a second polypeptide. In some embodiments, an isolated or recombinant CMR1 polypeptide is directly or indirectly bound to a solid support.

First claim

Opening claim text (preview).

What is claimed is: 1. An isolated or recombinant cold- and menthol-sensitive receptor (CMR1) polypeptide comprising SEQ ID NO:3 directly or indirectly attached to a detectable label or fused to a second polypeptide. 2. The isolated or recombinant polypeptide of claim 1 , wherein the CMR1 polypeptide is fused to a second polypeptide. 3. The isolated or recombinant polypeptide of claim 1 , wherein the label is selected from 32 P, fluorescent dyes, electron-dense reagents, biotin, digoxygenin, haptens, and radiolabeled proteins. 4. An isolated membrane comprising the isolated or recombinant polypeptide of claim 1 . 5. An isolated membrane comprising the isolated or recombinant polypeptide of claim 2 . 6. An isolated membrane comprising the isolated or recombinant polypeptide of claim 3 . 7. An isolated or recombinant cold- and menthol-sensitive receptor (CMR1) polypeptide comprising SEQ ID NO:3 directly or indirectly bound to a solid support. 8. The isolated or recombinant polypeptide of claim 7 , wherein the CMR1 polypeptide is bound covalently to the solid support. 9. The isolated or recombinant polypeptide of claim 7 , wherein the CMR1 polypeptide is bound non-covalently to the solid support. 10. The isolated or recombinant polypeptide of claim 7 , wherein the solid support comprises a nitrocellulose filter, a nylon filter, or a derivatized nylon filter.

Assignees

Inventors

Classifications

  • involving analysis of members of signalling pathways · CPC title

  • Fusion polypeptide · CPC title

  • Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (mutants or genetically engineered microorganisms, per se C12N1/00, C12N5/00, C12N7/00; new plants per se A01H; plant reproduction by tissue culture techniques A01H4/00; new animals per se A01K67/00; use of medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases, gene therapy A61K48/00) · CPC title

  • C07K14/705Primary

    Receptors; Cell surface antigens; Cell surface determinants {(tumour specific antigens C07K14/4748)} · CPC title

  • Assays involving receptors, cell surface antigens or cell surface determinants · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9932383B2 cover?
The present invention relates to regulation of cold sensation and pain. More particularly, the present invention is directed to nucleic acids encoding a member of the transient regulatory protein family, CMR1, which is involved in modulation of the perception of cold sensations and pain. In some embodiments, an isolated or recombinant CMR1 polypeptide is directly or indirectly attached to a det…
Who is the assignee on this patent?
Univ California
What technology area does this patent fall under?
Primary CPC classification C07K14/705. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).